United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 1,465,800 | 1,288,500 | 1,116,984 | 916,076 | 743,183 |
| Cost of Goods | 69,000 | 125,900 | 131,127 | 119,297 | 88,904 |
| Gross Profit | 1,396,800 | 1,162,600 | 985,857 | 796,779 | 654,279 |
| Operating Expenses | 697,800 | 624,700 | 693,485 | 375,430 | 337,401 |
| Operating Income | 699,000 | 538,800 | 292,499 | 421,646 | 317,782 |
| Interest Expense | 4,700 | 17,600 | 18,058 | 16,639 | 21,367 |
| Other Income | 350,100 | 4,000 | 4,462 | 35,664 | 2,702 |
| Pre-tax Income | 1,044,400 | 525,200 | 278,903 | 440,671 | 299,117 |
| Income Tax | 392,800 | 185,100 | 104,343 | 136,229 | 81,874 |
| Net Income Continuous | 651,600 | 340,100 | 174,560 | 304,442 | 217,243 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 625 |
| Net Income | $651,600 | $340,100 | $174,560 | $304,442 | $217,868 |
| EPS Basic Total Ops | 14.17 | 7.06 | 3.49 | 5.84 | 3.81 |
| EPS Basic Continuous Ops | 14.17 | 7.06 | 3.49 | 5.84 | 3.80 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.01 |
| EPS Diluted Total Ops | 12.72 | 6.28 | 3.28 | 5.71 | 3.67 |
| EPS Diluted Continuous Ops | 12.73 | 6.27 | 3.28 | 5.71 | 3.66 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.01 |
| EBITDA(a) | $731,900 | $571,000 | $340,860 | $464,459 | $362,150 |